High expression of both the ARL8B and BLOC1S2 genes, the latter of which is a BORC-subunit, was associated with poor survival rates in breast cancer patients and increased lymph node metastasis, both of which could account for the increased invasiveness. Here, ARL8B is linked to breast carcinoma.